Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation

Biology of Blood and Marrow Transplantation - Tập 24 - Trang e20-e25 - 2018
Livia Hegerova1, Adam Bachan2, Qing Cao3, Huong X. Vu4, John Rogosheske4, Mark T. Reding5,6, Claudio G. Brunstein6,7, Mukta Arora6,7, Celalettin Ustun6,7, Gregory M. Vercellotti6,7, Veronika Bachanova6,7
1Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, Washington
2Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota
3Biostatistics Core, Masonic Cancer Center, University of Minnesota Medical Center, Minneapolis, Minnesota
4Department of Clinical Pharmacology, University of Minnesota Medical Center, Minneapolis, Minnesota
5Center for Bleeding and Clotting Disorders, University of Minnesota Medical Center, Minneapolis, Minnesota
6Division of Hematology, Oncology and Transplantation, University of Minnesota Medical Center, Minneapolis, Minnesota
7Blood and Marrow Transplantation Program, University of Minnesota Medical Center, Minneapolis, Minnesota

Tài liệu tham khảo

Conlan, 1991, Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation, Bone Marrow Transplant., 7, 235 Haire, 1990, Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation, Cancer., 66, 900, 10.1002/1097-0142(19900901)66:5<900::AID-CNCR2820660515>3.0.CO;2-A Kansu, 2012, Thrombosis in stem cell transplantation, Hematology., 17, S159, 10.1179/102453312X13336169156735 Graf, 2012, Acute phase after haematopoietic stem cell transplantation: bleeding and thrombotic complications, Hamostaseologie., 32, 56, 10.5482/ha-1176 Gordon, 1991, High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma, Bone Marrow Transplant., 8, 497 Collins, 1992, on Willebrand factor as a marker of endothelial cell activation following BMT, Bone Marrow Transplant., 10, 499 Collins, 1994, Factor VIIa and other haemostatic variables following bone marrow transplantation, Thromb Haemost., 72, 28, 10.1055/s-0038-1648806 Chaturvedi, 2016, Venous thromboembolism in hematopoietic stem cell transplant recipients, Bone Marrow Transplant., 51, 473, 10.1038/bmt.2015.308 Bachanova, 2016, Adjusting cyclophosphamide dose in obese patients with lymphoma is safe and yields favorable outcomes after autologous hematopoietic cell transplantation, Biol Blood Marrow Transplant., 22, 571, 10.1016/j.bbmt.2015.10.012 Kaplan, 1958, Nonparametric-estimation from incomplete observations, J Am Stat Assoc., 53, 457, 10.1080/01621459.1958.10501452 Sorror, 2005, Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT, Blood., 106, 2912, 10.1182/blood-2005-05-2004 Yeral, 2015, Tunnelled central venous catheter-related problems in the early phase of haematopoietic stem cell transplantation and effects on transplant outcome, Turk J Haematol., 32, 51, 10.4274/tjh.2013.0278 Gerber, 2008, The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention, Blood., 112, 504, 10.1182/blood-2007-10-117051 Pihusch, 2002, Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients, Transplantation., 74, 1303, 10.1097/00007890-200211150-00018 Gonsalves, 2008, Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation, J Thromb Haemost., 6, 1468, 10.1111/j.1538-7836.2008.03077.x Lokich, 1983, Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy, Cancer., 52, 1586, 10.1002/1097-0142(19831101)52:9<1586::AID-CNCR2820520908>3.0.CO;2-4 Bern, 1990, Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial, Ann Intern Med., 112, 423, 10.7326/0003-4819-76-3-112-6-423 Holstein, 2017, Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial, Lancet Haematol., 4, e431, 10.1016/S2352-3026(17)30140-0 Martinod, 2014, Thrombosis: tangled up in NETs, Blood., 123, 2768, 10.1182/blood-2013-10-463646 Kimball, 2016, The emerging role of NETs in venous thrombosis and immunothrombosis, Front Immunol., 7:, 236, 10.3389/fimmu.2016.00236 Connolly, 2010, Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy, Thromb Res., 126, 113, 10.1016/j.thromres.2010.05.012 Blix, 2013, White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism—the Tromso study, PLoS One., 8, e73447, 10.1371/journal.pone.0073447 Khorana, 2008, Development and validation of a predictive model for chemotherapy-associated thrombosis, Blood., 111, 4902, 10.1182/blood-2007-10-116327 Dutia, 2012, Risk assessment models for cancer-associated venous thromboembolism, Cancer., 118, 3468, 10.1002/cncr.26597 Seifter, 1985, Abnormal coagulation results in patients with Hodgkin's disease, Am J Med., 78, 942, 10.1016/0002-9343(85)90216-5 Kaufman, 1990, Autologous bone marrow transplantation and factor XII, factor VII, and protein C deficiencies. Report of a new association and its possible relationship to endothelial cell injury, Cancer., 66, 515, 10.1002/1097-0142(19900801)66:3<515::AID-CNCR2820660319>3.0.CO;2-7 Alikhan, 2004, Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study, Arch Intern Med., 164, 963, 10.1001/archinte.164.9.963 Lagro, 2000, No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipients, Bone Marrow Transplant., 26, 1103, 10.1038/sj.bmt.1702675 Verso, 2005, Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients, J Clin Oncol., 23, 4057, 10.1200/JCO.2005.06.084 Young, 2009, Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial, Lancet., 373, 567, 10.1016/S0140-6736(09)60205-1 Debourdeau, 2013, International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer, J Thromb Haemost., 11, 71, 10.1111/jth.12071 Lyman, 2015, Bohlke K, Falanga A, et al.; American Society of Clinical Oncology. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update, J Oncol Pract., 11, e442, 10.1200/JOP.2015.004473 Kearon, 2012, Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest., 141, e419S, 10.1378/chest.11-2301 Bates, 2012, Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest., 141, e351S, 10.1378/chest.11-2299 Geerts, 2014, Central venous catheter-related thrombosis, Hematology Am Soc Hematol Educ Program., 2014, 306, 10.1182/asheducation-2014.1.306